Is There a Balancing Point for LDT Regulations?
CLP Editor Chris Wolski examines the need for LDT regulations, and issues an industry-wide call to action.
Read MorePosted by Chris Wolski | Jan 23, 2024 | Compliance |
CLP Editor Chris Wolski examines the need for LDT regulations, and issues an industry-wide call to action.
Read MorePosted by Chris Wolski | Jan 19, 2024 | Middleware & Software |
Low-code LIMS offer an adaptable, nimble platform, facilitating quick customization to cater to the specific, individualized needs of a lab.
Read MorePosted by Andy Lundin | Jan 19, 2024 | Education |
Industry leaders at COLA will share insights on advancements in lab science and crucial aspects of CLIA compliance and lab accreditation.
Read MorePosted by Chris Wolski | Jan 15, 2024 | Controls |
Adequately designed and clinically relevant QCs are a cornerstone in ensuring the reliability of Group B Streptococcus test results.
Read MorePosted by Chris Wolski | Jan 5, 2024 | Compliance |
CMS and the CDC issued Final Rulemaking [CMS-3326-F] to update the CLIA fees and clarify the CLIA fee regulations.
Read More